Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $15.7550 (0.48%) ($15.7550 - $15.7550) on Thu. Oct. 14, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.96% (three month average) | RSI | 42 | Latest Price | $15.7550(0.48%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -2.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -2.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) ARKG(46%) IBB(46%) ARKK(45%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.48% in a week (0% probabilities). VIXM(-40%) VXX(-28%) UNG(-15%) USO(-11%) TLT(-11%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.48% (StdDev 2.96%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $16.98 | 5 Day Moving Average | $16.69(-5.6%) | 10 Day Moving Average | $17.05(-7.6%) | 20 Day Moving Average | $16.98(-7.21%) | To recent high | -12.2% | To recent low | 31.2% | Market Cap | $1.171b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |